Cohance Lifesciences P/E Ratio

Current P/E Ratio

115.0

High Valuation

Very High - High growth expectations or significantly overvalued

Cohance Lifesciences (COHANCE) P/E ratio is 115.0 (High), EPS (TTM) ₹4.69, current price ₹417.10 on NSE vs historical average P/E of 54.6 (83.3th percentile) — Very High - High growth expectations or significantly overvalued. Read Cohance Lifesciences dividend payments for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/E Ratio 115.0

Current Price ₹417.10

EPS (TTM) ₹4.69

Exchange NSE

Valuation Signal

Signal Overvalued

Historical Avg 54.6

Historical Range 20.06 - 152.93

Percentile 83.3%

Sector Context

Sector Average 55.34

Sector Median 31.4

Sector Rank #11 of 194

Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹6.89

Mar 2026 ₹0.51

Sept 2025 ₹1.94

COHANCE P/E Ratio — Valuation Signal & Historical Context

Cohance Lifesciences P/E 115.0 vs historical average 54.6, range 20.06–152.93 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see COHANCE stock price BSE.

Stock appears overvalued with PE of 115.0, suggesting caution for new investments
Current PE is 110.6% above historical average
Trading at premium to sector average PE of 55.34

Cohance Lifesciences P/E Ratio Historical Trend

COHANCE annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 115.0 vs historical average 54.6. See COHANCE P/B ratio history to compare market price against book value per share.

COHANCE Historical P/E Ratio — EPS, Year-End Price & Valuation

Cohance Lifesciences annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year	P/E Ratio	EPS (₹)	Year-end Price (₹)	Exchange	Valuation
2025	152.93	7.34	₹1122.50	NSE	High
2024	61.41	11.73	₹720.35	NSE	High
2023	33.66	14.58	₹490.75	NSE	High
2022	33.09	14.88	₹492.35	NSE	High
2021	26.45	17.5	₹462.85	NSE	High
2020	20.06	16.8	₹337.05	NSE	Moderate

COHANCE vs Healthcare Peers — P/E Ratio Comparison

Cohance Lifesciences P/E 115.0 vs Healthcare average 55.34, median 31.4 — range 2.86–916.67.

Sector Average

55.34

Sector Median

31.4

Lowest P/E

2.86

Highest P/E

916.67

Companies

194

Company	Symbol	P/E Ratio	Market Cap (₹ Cr)	Valuation
Murae Organisor	MURAE	2.86	₹41	Low
Phaarmasia	PHRMASI	3.61	₹64	Low
Sunrest Lifescience	SUNREST	3.76	₹30	Low
Sun Pharma Advanced Rese…	SPARC	4.76	₹7,399	Low
Shelter Pharma	SHELTER	5.23	₹47	Low
Dipna Pharmachem	DPL	5.39	₹14	Low
JFL Life Sciences	JFLLIFE	5.41	₹68	Low
Amwill Health Care	AMWILL	7.26	₹83	Low
Zenith Drugs	ZENITHDRUG	7.69	₹84	Low
Galaxy Medicare	GML	7.8	₹27	Low